We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Firm Helps Clients Adopt New Blood-Labeling Standard

By HospiMedica staff writers
Posted on 07 Nov 2006
Software and services are being provided online to assist in the adoption of a new international blood-labeling standard.

The blood-labeling format provides a comprehensive and flexible system for assigning product codes. More...
New codes are built by specifying a combination of a component class, a modifier, core conditions, and a range of attributes. A unique combination of these values is assigned a product code number that becomes incorporated into the product-description database table, ensuring that the product will be accurately identified in any country in the world that is using the system.

The International Society of Blood Transfusion (ISBT) has revolutionized the information contained in a blood-component label by creating a new labeling standard called ISBT 128. Wyndgate Technologies (El Dorado Hills, CA, USA), a division of Global Med Technologies, is offering expert software and services to help its clients adopt this international standard for blood-component labeling by enrolling them in the Client Access Product Support Section of the company's website.

The new labeling standard relays critical information regarding each blood component in a secure electronic format to help prevent accidental misuse with blood products from multiple countries or facilities. ISBT 128 enables blood products collected in one location to be safely transfused across borders, governments, and healthcare systems. This standard will be useful in multinational disaster relief programs, widespread military operations, and international data stores.

When the requirement to adopt the ISBT 128 blood-labeling standard recently emerged in the United States, Wyndgate envisaged an increased demand for ISBT 128 education and services. The company developed an online educational series and has begun providing consulting services regarding implementing the standard. More than 500 individuals have attended one or more of the online education sessions that the company presented this year. Wyndgate will continue to offer additional ISBT 128 education sessions and services.

Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the company's SafeTrace Tx advanced transfusion management system and the SafeTrace donor management system provide vein-to-vein tracking from donor collection to patient transfusion.



Related Links:
Wyndgate Technologies

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gold Member
Blood Gas Analyzer
i-Check200
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.